The Data Monitoring Committee - bridging the gap between urology and public health epidemiology

被引：6

作者：

Smith, PH

机构：

来源：

BJU INTERNATIONAL | 2003年 / 92卷

关键词：

D O I：

10.1111/j.1465-5101.2003.04398.x

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：55 / 56

页数：2

共 5 条

[1] Prostate cancer mortality after introduction of prostate-specific antigen mass screening in the Federal State of Tyrol, Austria [J].

Bartsch, G ;

Horninger, W ;

Klocker, H ;

Reissigl, A ;

Oberaigner, W ;

Schönitzer, D ;

Severi, G ;

Robertson, C ;

Boyle, P .

UROLOGY, 2001, 58 (03) :417-424

[2] Prostate cancer mortality reduction by screening:: Power and time frame with complete enrollment in the European Randomised Screening for Prostate Cancer (ERSPC) trial [J].

de Koning, HJ ;

Liem, MK ;

Baan, CA ;

Boer, R ;

Schröder, FH ;

Alexander, FE .

INTERNATIONAL JOURNAL OF CANCER, 2002, 98 (02) :268-273

[3] BREAST-CANCER SCREENING WITH MAMMOGRAPHY - OVERVIEW OF SWEDISH RANDOMIZED TRIALS [J].

NYSTROM, L ;

RUTQVIST, LE ;

WALL, S ;

LINDGREN, A ;

LINDQVIST, M ;

RYDEN, S ;

ANDERSSON, I ;

BJURSTAM, N ;

FAGERBERG, G ;

FRISELL, J ;

TABAR, L ;

LARSSON, LG .

LANCET, 1993, 341 (8851) :973-978

[4] A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, Hemoccult [J].

Towler, B ;

Irwig, L ;

Glasziou, P ;

Kewenter, J ;

Weller, D ;

Silagy, C .

BRITISH MEDICAL JOURNAL, 1998, 317 (7158) :559-565

[5]

Wilson J. M. G., 1968, PRINCIPLES PRACTICE, DOI DOI 10.1001/ARCHINTE.1969.00300130131020

← 1 →